1. Long‐term cannabidiol treatment for seizures in patients with tuberous sclerosis complex: An open‐label extension trial. Issue 2 (27th December 2021) Authors: Thiele, Elizabeth A.; Bebin, E. Martina; Filloux, Francis; Kwan, Patrick; Loftus, Rachael; Sahebkar, Farhad; Sparagana, Steven; Wheless, James Journal: Epilepsia Issue: Volume 63:Issue 2(2022) Page Start: 426 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Long‐term efficacy and safety of cannabidiol in patients with treatment‐resistant epilepsies: Four‐year results from the expanded access program. Issue 3 (10th January 2023) Authors: Szaflarski, Jerzy P.; Devinsky, Orrin; Lopez, Merrick; Park, Yong D.; Zentil, Pilar Pichon; Patel, Anup D.; Thiele, Elizabeth A.; Wechsler, Robert T.; Checketts, Daniel; Sahebkar, Farhad Journal: Epilepsia Issue: Volume 64:Issue 3(2023) Page Start: 619 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Time to onset of cannabidiol treatment effect and resolution of adverse events in tuberous sclerosis complex: Post hoc analysis of randomized controlled phase 3 trial GWPCARE6. Issue 5 (4th March 2022) Authors: Wu, Joyce Y.; Cock, Hannah R.; Devinsky, Orrin; Joshi, Charuta; Miller, Ian; Roberts, Colin M.; Sanchez‐Carpintero, Rocio; Checketts, Daniel; Sahebkar, Farhad Journal: Epilepsia Issue: Volume 63:Issue 5(2022) Page Start: 1189 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗